Valo Health - FDA Collaborative Study in Human Cardiac Tissues Demonstrates Potential to Predict Clinical Efficacy of Cardiac Contractility Modulation Devices to Treat Heart Failure

/PRNewswire/ -- Valo Health, Inc ("Valo") shared the initial results of a collaborative study with the U.S. Food and Drug Administration (FDA), demonstrating...

Related Keywords

New York ,United States ,Boston ,Massachusetts ,San Francisco ,California ,Jennifer Hanley ,Michaelp Graziano ,Valo Biowire ,Graeme Bell ,Year Research Collaboration Between Valo ,Drug Administration ,Valo Health Inc ,Valo Health ,Findings Part ,Five Year Research Collaboration Between Valo ,Cardiac Contractility Modulation ,Translational Biology ,Opal Computational ,Flagship Pioneering ,Chief Communications ,Chief Financial ,Valo Health Llc ,